Literature DB >> 8035474

Viral induction of the human beta interferon promoter: modulation of transcription by NF-kappa B/rel proteins and interferon regulatory factors.

E Garoufalis1, I Kwan, R Lin, A Mustafa, N Pepin, A Roulston, J Lacoste, J Hiscott.   

Abstract

Multiple regulatory domains within the -100 region of the beta interferon (IFN-beta) promoter control the inducible response of the IFN gene to virus infection. In this study, we demonstrate that the formation of NF-kappa B-specific complexes on the positive regulatory domain II (PRDII) precedes the onset of detectable IFN-beta transcription in Sendai virus-infected cells. By using NF-kappa B subunit-specific antibodies, a temporal shift in the composition of NF-kappa B subunits in association with the PRDII domain is detected as a function of time after virus infection. Furthermore, a virus-induced degradation of I kappa B alpha (MAD3) protein is observed between 2 and 8 h after infection; at later times, de novo synthesis of I kappa B alpha restores I kappa B alpha to levels found in uninduced cells and correlates with the down regulation of IFN-beta transcription. In cotransfection experiments using various NF-kappa B subunit expression plasmids and two copies of PRDII/NF-kappa B linked to a chloramphenicol acetyltransferase reporter gene, we demonstrate that expression of p65, c-Rel, or p50 or combinations of p50-p65 and p65-c-Rel differentially stimulated PRDII-dependent transcription. Coexpression of I kappa B alpha completely abrogated p65-, c-Rel-, or p65-p50-induced gene activity. When the entire IFN-beta promoter (-281 to +19) was used in coexpression studies, synergistic stimulation of IFN-beta promoter activity was obtained when NF-kappa B subunits were coexpressed together with the IFN regulatory factor 1 (IRF-1) transcription factor. Overexpression of either I kappa B or the IRF-2 repressor was able to abrogate inducibility of the IFN-beta promoter. Thus, multiple regulatory events--including differential activation of DNA-binding NF-kappa B heterodimers, degradation of I kappa B alpha, synergistic interaction between IRF-1 and NF-kappa B, and decreased repression by I kappa B and IRF-2--are all required for the transcriptional activation of the IFN-beta promoter.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8035474      PMCID: PMC236410     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  74 in total

1.  NF-kappa B controls expression of inhibitor I kappa B alpha: evidence for an inducible autoregulatory pathway.

Authors:  S C Sun; P A Ganchi; D W Ballard; W C Greene
Journal:  Science       Date:  1993-03-26       Impact factor: 47.728

2.  The high mobility group protein HMG I(Y) is required for NF-kappa B-dependent virus induction of the human IFN-beta gene.

Authors:  D Thanos; T Maniatis
Journal:  Cell       Date:  1992-11-27       Impact factor: 41.582

3.  Anti-oncogenic and oncogenic potentials of interferon regulatory factors-1 and -2.

Authors:  H Harada; M Kitagawa; N Tanaka; H Yamamoto; K Harada; M Ishihara; T Taniguchi
Journal:  Science       Date:  1993-02-12       Impact factor: 47.728

4.  p105 and p98 precursor proteins play an active role in NF-kappa B-mediated signal transduction.

Authors:  F Mercurio; J A DiDonato; C Rosette; M Karin
Journal:  Genes Dev       Date:  1993-04       Impact factor: 11.361

5.  The proto-oncogene bcl-3 encodes an I kappa B protein.

Authors:  L D Kerr; C S Duckett; P Wamsley; Q Zhang; P Chiao; G Nabel; T W McKeithan; P A Baeuerle; I M Verma
Journal:  Genes Dev       Date:  1992-12       Impact factor: 11.361

6.  The precursor of NF-kappa B p50 has I kappa B-like functions.

Authors:  N R Rice; M L MacKichan; A Israël
Journal:  Cell       Date:  1992-10-16       Impact factor: 41.582

7.  I kappa B interacts with the nuclear localization sequences of the subunits of NF-kappa B: a mechanism for cytoplasmic retention.

Authors:  A A Beg; S M Ruben; R I Scheinman; S Haskill; C A Rosen; A S Baldwin
Journal:  Genes Dev       Date:  1992-10       Impact factor: 11.361

8.  The p50 subunit of NF-kappa B associates with the NF-IL6 transcription factor.

Authors:  K P LeClair; M A Blanar; P A Sharp
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

9.  Characterization of TH3, an induction-specific protein interacting with the interferon beta promoter.

Authors:  L Cohen; J Hiscott
Journal:  Virology       Date:  1992-12       Impact factor: 3.616

10.  Interferon-beta promoters contain a DNA element that acts as a position-independent silencer on the NF-kappa B site.

Authors:  M Nourbakhsh; K Hoffmann; H Hauser
Journal:  EMBO J       Date:  1993-02       Impact factor: 11.598

View more
  37 in total

1.  Interferon regulatory factor 2 represses the Epstein-Barr virus BamHI Q latency promoter in type III latency.

Authors:  L Zhang; J S Pagano
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

2.  Nuclear factor κB subunits RelB and cRel negatively regulate Toll-like receptor 3-mediated β-interferon production via induction of transcriptional repressor protein YY1.

Authors:  Jakub Siednienko; Ashwini Maratha; Shuo Yang; Malgorzata Mitkiewicz; Sinéad M Miggin; Paul N Moynagh
Journal:  J Biol Chem       Date:  2011-11-07       Impact factor: 5.157

3.  Phosphorylation of IkappaBalpha in the C-terminal PEST domain by casein kinase II affects intrinsic protein stability.

Authors:  R Lin; P Beauparlant; C Makris; S Meloche; J Hiscott
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

4.  NF-kappaB signaling differentially regulates influenza virus RNA synthesis.

Authors:  Naveen Kumar; Zhong-Tao Xin; Yuhong Liang; Hinh Ly; Yuying Liang
Journal:  J Virol       Date:  2008-08-13       Impact factor: 5.103

5.  Drosophila immunity. A sequence homologous to mammalian interferon consensus response element enhances the activity of the diptericin promoter.

Authors:  P Georgel; C Kappler; E Langley; I Gross; E Nicolas; J M Reichhart; J A Hoffmann
Journal:  Nucleic Acids Res       Date:  1995-04-11       Impact factor: 16.971

6.  Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation.

Authors:  R Lin; C Heylbroeck; P M Pitha; J Hiscott
Journal:  Mol Cell Biol       Date:  1998-05       Impact factor: 4.272

7.  The clinically approved proteasome inhibitor PS-341 efficiently blocks influenza A virus and vesicular stomatitis virus propagation by establishing an antiviral state.

Authors:  Sabine Eva Dudek; Christina Luig; Eva-Katharina Pauli; Ulrich Schubert; Stephan Ludwig
Journal:  J Virol       Date:  2010-06-30       Impact factor: 5.103

8.  Low type I interferon response in COVID-19 patients: Interferon response may be a potential treatment for COVID-19.

Authors:  Ahmed Abdulwahid Salman; Mohammed Hussein Waheed; Akeel Abd Ali-Abdulsahib; Zeenah Weheed Atwan
Journal:  Biomed Rep       Date:  2021-03-09

9.  cIRF-3, a new member of the interferon regulatory factor (IRF) family that is rapidly and transiently induced by dsRNA.

Authors:  C E Grant; M Z Vasa; R G Deeley
Journal:  Nucleic Acids Res       Date:  1995-06-25       Impact factor: 16.971

10.  Primary activation of interferon A and interferon B gene transcription by interferon regulatory factor 3.

Authors:  Y T Juang; W Lowther; M Kellum; W C Au; R Lin; J Hiscott; P M Pitha
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.